JPRN-UMIN000048870已完成Unknown
A multicenter study to evaluate the ability of NGS analysis of plasma samples to detect driver oncogenes in lung cancer - A multicenter study evaluating the NGS analysis of plasma samples in lung cancer
Cancer Institute Hospital of Japan Foundation for Cancer Research0 个研究点目标入组 302 人开始时间: 2022年9月7日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 302
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A Multicenter, Multinational Study to Assess the Safety and Efficacy of Antithrombin alfa in Hereditary Antithrombin (AT) Deficient Patients in High-Risk Situations for ThrombosisHereditary Antithrombin Deficient Patients in High risk Situations for Thrombosis.EUCTR2005-002014-38-GBGTC Biotherapeutics Inc.17
进行中（未招募）
不适用
A Multicenter, Multinational Study to Assess the Safety and Efficacy of Antithrombin alfa in Hereditary Antithrombin (AT) Deficient Patients in High-Risk Situations for ThrombosisEUCTR2005-002014-38-DEGTC Biotherapeutics Inc.17
进行中（未招募）
不适用
A Multicenter, Multinational Study to Assess the Safety and Efficacy of Antithrombin alfa in Hereditary Antithrombin (AT) Deficient Patients in High-Risk Situations for ThrombosisHereditary Antithrombin Deficient Patients in High risk Situations for Thrombosis.EUCTR2005-002014-38-SEGTC Biotherapeutics Inc.17
进行中（未招募）
不适用
A Multicenter, Multinational Study to Assess the Safety and Efficacy of Antithrombin alfa in Hereditary Antithrombin AT Deficient Patients in High-Risk Situations for Thrombosis - NDHereditary Antithrombin AT Deficient Patients in High-Risk Situations for ThrombosisMedDRA version: 6.1Level: PTClassification code 10020608EUCTR2005-002014-38-ITGTC BIOTHERAPEUTICS17
进行中（未招募）
不适用
A Multicenter, Multinational Study to Assess the Safety and Efficacy of Antithrombin alfa in Hereditary Antithrombin (AT) Deficient Patients in High-Risk Situations for ThrombosisEUCTR2005-002014-38-ATGTC Biotherapeutics Inc.17